512,221 results on '"Immune system"'
Search Results
2. Effects of Almond Consumption on Innate and Adaptive Immune System (AlmondIS)
- Published
- 2024
3. Inflammation in Posttraumatic Stress Disorder: Dysregulation or Recalibration?
- Author
-
Patas, Kostas, Baker, Dewleen, Chrousos, George, and Agorastos, Agorastos
- Subjects
Posttraumatic stress disorder (PTSD) ,anti-inflammatory agents. ,immune system ,inflammation ,microglia ,neurobiology ,Humans ,Stress Disorders ,Post-Traumatic ,Inflammation ,Stress ,Psychological ,Microglia ,Central Nervous System Diseases - Abstract
Despite ample experimental data indicating a role of inflammatory mediators in the behavioral and neurobiological manifestations elicited by exposure to physical and psychologic stressors, causative associations between systemic low-grade inflammation and central nervous system inflammatory processes in posttraumatic stress disorder (PTSD) patients remain largely conceptual. As in other stress-related disorders, pro-inflammatory activity may play an equivocal role in PTSD pathophysiology, one that renders indiscriminate employment of anti-inflammatory agents of questionable relevance. In fact, as several pieces of preclinical and clinical research convergingly suggest, timely and targeted potentiation rather than inhibition of inflammatory responses may actually be beneficial in patients who are characterized by suppressed microglia function in the face of systemic low-grade inflammation. The deleterious impact of chronic stress-associated inflammation on the systemic level may, thus, need to be held in context with the - often not readily apparent - adaptive payoffs of low-grade inflammation at the tissue level.
- Published
- 2024
4. Inflammation and immune system pathways as biological signatures of adolescent depression—the IDEA-RiSCo study
- Author
-
Zonca, Valentina, Marizzoni, Moira, Saleri, Samantha, Zajkowska, Zuzanna, Manfro, Pedro H, Souza, Laila, Viduani, Anna, Sforzini, Luca, Swartz, Johnna R, Fisher, Helen L, Kohrt, Brandon A, Kieling, Christian, Riva, Marco Andrea, Cattaneo, Annamaria, and Mondelli, Valeria
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Research ,Serious Mental Illness ,Mental Health ,Brain Disorders ,Depression ,Pediatric ,Mental Illness ,Major Depressive Disorder ,Women's Health ,Aetiology ,2.1 Biological and endogenous factors ,Inflammatory and immune system ,Good Health and Well Being ,Humans ,Adolescent ,Male ,Female ,Depressive Disorder ,Major ,Brazil ,Inflammation ,Sex Factors ,Immune System ,Cytokines ,Public Health and Health Services ,Psychology ,Clinical sciences ,Neurosciences ,Biological psychology - Abstract
The biological mechanisms underlying the onset of major depressive disorder (MDD) have predominantly been studied in adult populations from high-income countries, despite the onset of depression typically occurring in adolescence and the majority of the world's adolescents living in low- and middle-income countries (LMIC). Taking advantage of a unique adolescent sample in an LMIC (Brazil), this study aimed to identify biological pathways characterizing the presence and increased risk of depression in adolescence, and sex-specific differences in such biological signatures. We collected blood samples from a risk-stratified cohort of 150 Brazilian adolescents (aged 14-16 years old) comprising 50 adolescents with MDD, 50 adolescents at high risk of developing MDD but without current MDD, and 50 adolescents at low risk of developing MDD and without MDD (25 females and 25 males in each group). We conducted RNA-Seq and pathway analysis on whole blood. Inflammatory-related biological pathways, such as role of hypercytokinemia/hyperchemokinemia in the pathogenesis of influenza (z-score = 3.464, p
- Published
- 2024
5. Diversity and plasticity of virulent characteristics of 'Entamoeba histolytica'
- Author
-
Yanagawa, Yasuaki and Singh, Upinder
- Published
- 2023
6. Safety and Pharmacokinetics of IMT504, an Immunomodulator and Tissue Repair Inducer (ECDA000/02)
- Author
-
Immunalgia Therapeutics S.A.
- Published
- 2024
7. Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder
- Published
- 2024
8. An Experimental Medicine Clinical Study to Compare Peripheral Immune System From Subjects Without Cancer Diagnosis and Patients With Solid Tumours. (IMMUNOPBMC)
- Published
- 2024
9. Evaluation of the Effects of Routine Intake of Fresh vs- Pasteurized Yoghurt on the Immune System in Healthy Adults (YASI-03)
- Author
-
Danone Institute International, University of Seville, and Alfredo Corell, Proffesor
- Published
- 2024
10. Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach (XCVD)
- Author
-
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) and Dr. Lajos Marko, Dr.
- Published
- 2024
11. Aromatherapy for Upper Respiratory Health
- Author
-
Prodeco Pharma
- Published
- 2024
12. Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first‐line antihypertensive drugs.
- Author
-
González‐Correa, Cristina, Moleón, Javier, Miñano, Sofía, Robles‐Vera, Iñaki, Toral, Marta, Barranco, Antonio Manuel, Martín‐Morales, Natividad, O'Valle, Francisco, Guerra‐Hernández, Eduardo, Sánchez, Manuel, Gómez‐Guzmán, Manuel, Jiménez, Rosario, Romero, Miguel, and Duarte, Juan
- Subjects
- *
FECAL microbiota transplantation , *ANTIHYPERTENSIVE agents , *ANAEROBIC bacteria , *BLOOD pressure , *NADPH oxidase - Abstract
Background and Purpose: This study analyses whether first‐line antihypertensive drugs ameliorate the dysbiosis state in hypertension, and to test if this modification contributes to their blood pressure (BP) lowering properties in a genetic model of neurogenic hypertension. Experimental Approach: Twenty‐week‐old male Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) were untreated or treated with captopril, amlodipine or hydrochlorothiazide. A faecal microbiota transplantation (FMT) experiment was also performed by gavage of faecal content from donor SHR‐treated groups to SHR recipients for 3 weeks. Key results: Faeces from SHR showed gut dysbiosis, characterized by lower acetate‐ and higher lactate‐producing bacteria and lower strict anaerobic bacteria. All three drugs increased the anaerobic bacteria proportion, captopril and amlodipine restored the proportion of acetate‐producing bacterial populations to WKY levels, whereas hydrochlorothiazide decreased butyrate‐producing bacteria. Captopril and amlodipine decreased gut pathology and permeability and attenuated sympathetic drive in the gut. Both drugs decreased neuroinflammation and oxidative stress in the hypothalamic paraventricular nuclei. Hydrochlorothiazide was unable to reduce neuroinflammation, gut sympathetic tone and gut integrity. FMT from SHR‐amlodipine to SHR decreased BP, ameliorated aortic endothelium‐dependent relaxation to acetylcholine, lowered NADPH oxidase activity, aortic Th17 infiltration and reduced neuroinflammation, whereas FMT from SHR‐hydrochlorothiazide did not have these effects. Conclusions and Implications: First‐line antihypertensive drugs induced different modifications of gut integrity and gut dysbiosis in SHR, which result in no contribution of microbiota in the BP lowering effects of hydrochlorothiazide, whereas the vasculo‐protective effect induced by amlodipine involves gut microbiota reshaping and gut‐immune system communication. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Bacterial endometritis-induced changes in the endometrial proteome in mares: Potential uterine biomarker for bacterial endometritis.
- Author
-
Da Silva, E., Martín-Cano, F.E., Gómez-Arrones, V., Gaitskell-Phillips, G., Alonso, J.M., Rey, J., Becerro, L., Gil, M.C., Peña, F.J., and Ortega-Ferrusola, C.
- Subjects
- *
MARES , *ENDOMETRITIS , *COMPLEMENT (Immunology) , *PEPTIDE antibiotics , *MICROFILAMENT proteins , *BIOMARKERS , *CYTOSKELETON , *PLANT defenses - Abstract
Equine endometritis is one of the main causes of subfertility in the mare. Unraveling the molecular mechanisms involved in this condition and pinpointing proteins with biomarker potential could be crucial in both diagnosing and treating this condition. This study aimed to identify the endometritis-induced changes in the endometrial proteome in mares and to elucidate potential biological processes in which these proteins may be involved. Secondly, biomarkers related to bacterial endometritis (BE) in mares were identified. Uterine lavage fluid samples were collected from 28 mares (14 healthy: negative cytology and culture, and no clinical signs and 14 mares with endometritis: positive cytology and culture, in addition to clinical signs). Proteomic analysis was performed with a UHPLC-MS/MS system and bioinformatic analysis was carried out using Qlucore Omics Explorer. Gene Ontology enrichment and pathway analysis (PANTHER and KEGG) of the uterine proteome were performed to identify active biological pathways in enriched proteins from each group. Quantitative analysis revealed 38 proteins differentially abundant in endometritis mares when compared to healthy mares (fold changes >4.25, and q-value = 0.002). The proteins upregulated in the secretome of mares with BE were involved in biological processes related to the generation of energy and REDOX regulation and to the defense response to bacterium. A total of 24 biomarkers for BE were identified using the biomarker workbench algorithm. Some of the proteins identified were related to the innate immune system such as isoforms of histones H2A and H2B involvement in neutrophil extracellular trap (NET) formation, complement C3a, or gelsolin and profilin, two actin-binding proteins which are essential for dynamic remodeling of the actin cytoskeleton during cell migration. The other group of biomarkers were three known antimicrobial peptides (lysosome, equine cathelicidin 2 and myeloperoxidase (MPO)) and two uncharacterized proteins with a high homology with cathelicidin families. Findings in this study provide the first evidence that innate immune cells in the equine endometrium undergo reprogramming of metabolic pathways similar to the Warburg effect during activation. In addition, biomarkers of BE in uterine fluid of mares including the new proteins identified, as well as other antimicrobial peptides already known, offer future lines of research for alternative treatments to antibiotics. • Mares with bacterial endometritis exhibited a significantly higher relative abundance of endometrial proteins compared to clinically healthy mares. • The proteins upregulated in the secretome of mares with bacterial endometritis were involved in biological processes related to the generation of energy and REDOX regulation and to the defense response to bacterium (neutrophil extracellular trap (NET) formation pathway). • A total of 24 biomarkers for bacterial endometritis were identified. Some of the proteins identified were related to the innate immune system such as isoforms of histones H2A and H2B, complement C3a, or gelsolin and profilin. The other group of biomarkers were three known antimicrobial peptides (lysosome, equine cathelicidin 2 and MPO) and two uncharacterized proteins with a high homology with cathelicidin families. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Understanding Of Concept Of Viruddhahara (Incompatible Food) In The Light Of Conventional Science.
- Author
-
Mishra, Mriganka and Kapgate, Sarita M.
- Subjects
GASTROINTESTINAL system ,AYURVEDIC medicine ,FOOD industry ,IMMUNE system ,SECRETION - Abstract
Food incompatibility (Virudhaahar) is described elaborately in Ayurveda health science. Various types of food incompatibilities with the examples of combination are mentioned in the Ayurveda literatures like in Charaka Samhita and Susruta Samhita but these type of food combinations are not practiced in today's era. Today with the change in lifestyle, food processing methods and the combination of food articles are also modified. So, there is a need to review and identify new food incompatibilities, which are currently practiced as per Ayurvedic perspectives. Such food combinations can prove harmful, which may be imparting its untoward effects on the immune system, cellular metabolism, hormone secretions, and hence, the need to acknowledge this health issue arise. The unwanted effect of wrong combinations of food is not limited up to gastrointestinal tract only but may hamper the major systems of the body as well. Thereby, unwanted side effects can emerge inside the body when two or more types of foods are consumed together. This review article is an endeavour to compile and critically analyse the researches reporting the incompatible food effects with their probable pathogenesis and to identify new food incompatibilities, which are currently practiced. [ABSTRACT FROM AUTHOR]
- Published
- 2024
15. Physical activity and circulating inflammatory markers and cytokines during pregnancy: A population‐based cohort study.
- Author
-
Dhar, Poshmaal, Sominsky, Luba, O'Hely, Martin, Dawson, Samantha, Collier, Fiona, Tang, Mimi L. K., Mansell, Toby, Burgner, David, Smith, Craig, Hyde, Natalie, Downing, Katherine, Hesketh, Kylie D., Ponsonby, Anne‐Louise, and Vuillermin, Peter
- Subjects
- *
GESTATIONAL diabetes , *PHYSICAL activity , *C-reactive protein , *IMMUNE system , *IMMUNE response - Abstract
Introduction: Physical activity (PA) during pregnancy has numerous benefits, which may be mediated via effects on the immune system. However, supportive evidence is inconsistent and is mainly from studies in high‐risk groups. We estimated the effect of PA during pregnancy on systemic inflammatory markers and cytokines in mothers recruited in the Barwon infant study. Material and Methods: The Barwon infant study is a prebirth cohort of 1064 mothers recruited in the Barwon Region of Victoria, Australia. Participants reported their previous week's PA at their 28‐week antenatal appointment using the International PA Questionnaire. Women were grouped into low, moderate, and high PA categories based on daily duration and weekly frequency of walking, moderate‐ or vigorous‐intensity PA. Women reporting moderate levels of PA, consistent with current recommendations, served as the comparison group. Markers of systemic inflammation, high‐sensitivity C‐reactive protein (hsCRP), glycoprotein acetyls (GlycA), and 17 cytokines were measured at 28 weeks gestation and log transformed as appropriate. Regression analyses adjusted for maternal smoking, gestational diabetes mellitus, prepregnancy BMI, and household size were performed. Results: Compared to women in the moderate group (n = 371, 42%), women reporting low PA (n = 436, 50%) had 10.1% higher hsCRP (95% CI (3.7% to 16.6%), p < 0.01) while women in high PA (n = 76, 9%) had a 14% higher hsCRP (95% CI (3.1% to 24.8%), p = 0.01). Women in the high PA category had higher interleukin (IL)‐4 (q = 0.03) and IL‐9 (q = 0.03) levels compared to those in moderate category. Each vigorous MET minute/week was associated with lower GlycA (β = −0.004, 95% CI (−0.044 to 0.035); p = 0.03). Conclusions: Low and high PA are each associated with higher hsCRP than moderate PA, suggesting that undertaking the recommended moderate PA during pregnancy decreases systemic inflammation. High PA affects T cell‐associated cytokines during pregnancy. Evidence from our study suggests that PA can modulate the immune responses during pregnancy. Studies are now required to assess whether PA during pregnancy impacts maternal and infant clinical outcomes by modifying inflammatory responses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Postbiotics as a health-promoting technique: A review article on scientific and commercial interest.
- Author
-
Heniedy, Amira M., Mahdy, Dina M., Abo Elenien, Wesam.I., Mourad, Sohaila, and El-Kadi, Rana A.
- Subjects
- *
ARTIFICIAL intelligence , *BIOTECHNOLOGY , *EXPORT marketing , *IMMUNE system , *BIOMASS energy - Abstract
Postbiotics are recognized as the most innovative, multidisciplinary biotechnological approach. Each year, the quantity of research results and patents grows. According to PubMed, around 250 research papers in the field of postbiotics were cited in 2023, followed by approximately 74 publications in early 2024. Concurrently, the global postbiotic market has grown significantly, becoming one of the most formidable markets in the biotic sector. Yet, there is no thorough analysis of the current progress of the postbiotics market or how research studies and discoveries can impact the quantity and quality of postbiotics. This review provides an insightful perspective on current consumer brands and highlights the latest therapeutic and non- therapeutic applications in the postbiotics market. In comparison to other therapeutic agents such as antibiotics, probiotics, and growth boosters, this review suggests that postbiotics are an effective and eco-friendly alternative therapy. Furthermore, postbiotics, an industrially sustainable technology, are highlighted, shedding light on the development of biotic markets. [Display omitted] • Postbiotics are a promising trend in both therapeutic and non-therapeutic markets. • Postbiotics enhance the immune system and strengthen defensive mechanisms against various disorders. • Postbiotics are an eco-friendly alternative to antibiotics and growth promoter therapies. • Postbiotic research enriches biotic markets by developing new detergents, biofuels, and artificial intelligence-based research tools. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Nutrition and chronic musculoskeletal pain: A narrative review and directions for temporomandibular disorder research and management.
- Author
-
Mesquita, Maria Laura Marreiro, Magalhães, Aghata Kelma Palacio Gomes, Nascimento, Matheus Vieira, Pascoal, Samuel Chillavert Dias, Pontes, Karina Matthes de Freitas, Bonjardim, Leonardo Rigoldi, Conti, Paulo César Rodrigues, and Pinto Fiamengui, Lívia Maria Sales
- Subjects
- *
TEMPOROMANDIBULAR disorders , *PACKAGED foods , *FOOD quality , *MUSCULOSKELETAL pain , *CHRONIC pain , *NUTRITIONAL assessment , *CONVENIENCE foods , *IMMUNE system , *CELLULAR signal transduction , *OXIDIZING agents , *PAIN management , *ORGANIC compounds , *INFLAMMATION , *NUTRITION , *DIET , *DISEASE complications - Abstract
Background: Recent evidence suggests neuro‐immune mechanisms may link dietary patterns to chronic painful conditions (CPC). In the research field of oro‐facial pain (OFP), studies focuses primarily on dietary mechanical limitations due to pain and dysfunction. Objective: This narrative review aimed to overview the role of nutrition on CPC, with emphasis on temporomandibular disorder (TMD), enlightening OFP researcher on dietary assessment possibilities and providing directions for studies in the field of OFP and nutrition. Methods: A PubMed database search was performed using the MeSH and non‐MeSH descriptors: "temporomandibular joint disorder"; "orofacial pain"; "musculoskeletal pain"; "chronic pain disorders"; "nutrition"; "diet"; "dietary therapy"; "dietary intake" and "inflammation". No time restrictions were applied. Literature reviews, systematic reviews, meta‐analyses and clinical and pre‐clinical trials were included. Results: Exogenous oxidants from unhealthy dietary patterns may contribute to peripheral and central pro‐inflammatory immune signalling leading to peripheral and central sensitization. Furthermore, diets rich in bioactive compounds are suggested to contribute to pain management of CPC. High dietary intake of ultra‐processed foods impacts the quality of the diet and shows adverse health outcomes. In this context, the role of nutrition on TMD remains overlooked. Conclusion: Considering diet may influence CPC, allied with the scarcity of studies evaluating the role of nutrition on TMD, well‐designed clinical trials based on dietary assessments and measurements capable of evaluating food quality, UPF consumption and nutrient adequacy—added to serum nutrient levels evaluation—are suggested. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Money or health? The effect of pathogen avoidance motives and life history strategies on health‐economic trade‐offs during the COVID‐19 pandemic.
- Author
-
Ma, Qingyi, Ji, Tingting, and Guo, Yongyu
- Subjects
- *
LIFE history interviews , *POLICY sciences , *INFECTION control , *HEALTH status indicators , *RESEARCH funding , *SOCIOECONOMIC factors , *POPULATION health , *BLOODBORNE infections , *AVOIDANCE conditioning , *DECISION making , *EVALUATION of medical care , *ECONOMIC status , *COST benefit analysis , *PSYCHOLOGICAL adaptation , *IMMUNE system , *DESCRIPTIVE statistics , *MOTIVATION (Psychology) , *PSYCHOLOGY , *PATHOGENIC microorganisms , *RESEARCH methodology , *THEORY , *PUBLIC health , *AVERSION , *FACTOR analysis , *CONFIDENCE intervals , *DATA analysis software , *COVID-19 pandemic , *COVID-19 , *IMMUNITY , *SARS-CoV-2 , *AVOIDANCE (Psychology) - Abstract
The COVID‐19 pandemic has caused governments and individuals to face important but difficult trade‐offs between health and the economy. How do individuals choose between health and economic outcomes during the pandemic? Based on the behavioural immune system (BIS) theory and the life history (LH) theory, the present study examined the effects of individual differences in pathogen disgust sensitivity and life history strategy on people's health‐economic trade‐offs during the COVID‐19 pandemic. Results of an online study (N = 300) showed that people with higher pathogen disgust sensitivity felt less sense of control during the pandemic, and therefore chose health‐related options over economic‐related options. In addition, the association between pathogen disgust sensitivity and health outcome preference only existed in people with relatively faster life history strategies. Further, people's health‐economic trade‐offs were not influenced by their current economic status. Findings have important implications for policymakers and the public to understand people's health‐economic choices during the pandemic. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. The presence and clinical significance of autoantibodies in amyotrophic lateral sclerosis: a narrative review.
- Author
-
Liu, Shen, Hong, Ye, Wang, Bian-Rong, Wei, Zi-Qiao, Zhao, Hong-Dong, Jiang, Teng, Zhang, Ying-Dong, and Shi, Jian-Quan
- Subjects
- *
AMYOTROPHIC lateral sclerosis , *CEREBROSPINAL fluid , *MOTOR neurons , *NEURODEGENERATION , *IMMUNE system - Abstract
Amyotrophic lateral sclerosis (ALS) is a debilitating and rapidly fatal neurodegenerative disease, which is characterized by the selective loss of the upper and lower motor neurons. The pathogenesis of ALS remains to be elucidated and has been connected to genetic, environmental and immune conditions. Evidence from clinical and experimental studies has suggested that the immune system played an important role in ALS pathophysiology. Autoantibodies are essential components of the immune system. Several autoantibodies directed at antigens associated with ALS pathogenesis have been identified in the serum and/or cerebrospinal fluid of ALS patients. The aim of this review is to summarize the presence and clinical significance of autoantibodies in ALS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Boron Facilitates Amelioration of Hepatic Injury by the Osmolyte Glycine and Resolves Injury by Improving the Tissue Redox Homeostasis.
- Author
-
Farooqui, Humaira, Anjum, Farah, Lebeche, Djamel, and Ali, Shakir
- Subjects
- *
LIVER disease prevention , *OXIDATION-reduction reaction , *PROTEINS , *HOMEOSTASIS , *HEPATOTOXICOLOGY , *RESEARCH funding , *NITRIC oxide , *TISSUES , *LIPIDS , *APOPTOSIS , *SULFUR compounds , *BORON compounds , *DESCRIPTIVE statistics , *IMMUNE system , *OXIDATIVE stress , *LIVER diseases , *RATS , *GLYCINE , *ANIMAL experimentation , *ANTIOXIDANTS , *LIVER , *CELL survival , *DIETARY supplements - Abstract
Background: Glycine is a conditional non-essential amino acid in human and other mammals. It is abundant in the liver and is known for a wide spectrum of characteristics including the antioxidant, antiinflammatory, immunomodulatory, and cryoprotective effects. The amino acid is a naturally occurring osmolyte compatible with protein surface interactions and has been reported in literature as a potent therapeutic immuno-nutrient for liver diseases such as alcoholic liver disease. Oral glycine administration protects ethanol-induced liver injury, improves serum and tissue lipid profile, and alleviates hepatic injury in various conditions. In recent years, sodium salt of boron (borax) has been reported for its beneficial effects on cellular stress, including the effects on cell survival, immunity, and tissue redox state. Incidentally both glycine and boron prevent apoptosis and promote cell survival under stress. Objective: This study investigates the beneficial effect of borax on liver protection by glycine. Methods: Briefly, liver toxicity was induced in rats by a single intraperitoneal injection of thioacetamide (400 mg/kg b. wt.). Results: Significant changes in oxidative stress and liver function test parameters, the molybdenum Fe-S flavin hydroxylase activity, nitric oxide and tissue histopathology were observed in thioacetamide treated positive control group. The changes were ameliorated both by glycine as well as borax, but the combinatorial treatment yielded a better response indicating the impact of boron supplementation on glycine mediated protection of liver injury in experimental animal model. Conclusions: The study has clinical implications as the hepatotoxicity caused by thioacetamide mimics features of hepatitis C infection in human. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Beneficial roles of nutrients as immunostimulants in aquaculture: A review.
- Author
-
Vijayaram, Seerengaraj, Ringø, Einar, Zuorro, Antonio, van Doan, Hien, and Yunzhang Sun
- Subjects
- *
PROTEIN deficiency , *IMMUNOLOGICAL adjuvants , *AQUACULTURE industry , *FISHERIES , *IMMUNE system - Abstract
Protein deficiency is a major difficulty for human needs in the past few decades, while different types of aquatic species are rich in high quality protein. Therefore, aquaculture is considered as the main developing food production sector globally. Bacterial infections are the main problem for aquaculture, and their outbreaks have a great impact on productivity, and previously indiscriminate use of antibiotics to control them. However, the emergence of multidrug-resistant pathogens might lead to sudden infectious disease outbreaks resulting in serious economic loss. Immunostimulants application is an effective technique to protect and enhance the immune system of aquatic animals and therefore improve aquaculture production. Nutrient immunostimulants such as essential fatty acids, amino acids, vitamins, and minerals are the most important responsibility to improve aquaculture production, as well as the cost of this method, which is effective, non-toxic, and environment friendly. These nutrient immunostimulants are supportive to increase the immune system, antioxidant, antiinflammatory, and infection resistance of aquatic animals. In addition, nutritional feed additives improved feed palatability and the excellence of aquatic products and also enhance gut functions. Some information is available on nutrient immunostimulants in aquaculture applications, and this review provides information on different kinds of nutritional administration used in aquaculture to enhance positive impacts on aquatic animals' health as well as feed quality development. This review will provide theoretical references for the application of nutrient immunostimulants in aquatic feeds. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Rab proteins in fish and crustaceans: an overview.
- Author
-
Zhu, Lei, Gu, Yanlong, Kong, Yiming, Wang, Xinru, Li, Hao, Hou, Libo, and Kong, Xianghui
- Subjects
- *
AQUATIC animals , *CELL physiology , *CELLULAR signal transduction , *PHAGOCYTOSIS , *IMMUNE system - Abstract
The Rab family of proteins is involved in organelle regulation, trafficking, signal transduction, mitosis, phagocytosis, growth differentiation, cytoskeleton protein depolymerization and other cellular functions and abnormal expression has been associated with many pathologies, including cancer. Previous work has focused on Rab function in higher animals but fish, crustaceans and other aquatic animals also express the Rab proteins. The current review summarizes research progress on Rab proteins, focusing on immune defense against pathogens in aquatic animals. Some differences in Rab protein function between aquatic and higher animals were found and greater involvement in the fish and crustacean immune system than that of higher animals. Novel insights into Rab protein in aquatic animals are offered with implications for the development of aquaculture strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Expression of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) in Normal Wistar Rat Post-Cheral® Administration.
- Author
-
Asyhari, Firda Nuri, Zulfatim, Heni Sukma, Putri, Nenis Try Melani, Dliyauddin, Moh, Jamil, Ahmad Shobrun, Soewondo, Aris, Natsir, Muhammad Halim, Ibrahim, Mansur, Rahayu, Sri, Djati, Muhammad Sasmito, and Rifa'i, Muhaimin
- Subjects
- *
IMMUNOGLOBULIN G , *LABORATORY rats , *IMMUNOGLOBULIN M , *TURMERIC , *IMMUNE system , *SPLEEN - Abstract
Maintaining immunoglobulin levels in the body is important to protect the body from exposure to pathogens. One effort can be made by consuming herbs containing immunomodulatory compounds, such as Cheral®, which includes a combination of herbs Phyllanthus niruri and Curcuma longa. This research aims to determine the expression of immunoglobulin M (IgM) and immunoglobulin G (IgG) following the administration of Cheral® to Wistar rats. The study was conducted in vivo, utilizing 24 healthy male Wistar rats for a 90-day treatment period. The research was divided into four treatment groups, including a control group and three dosage groups: Dose 1 (156.25 mg/kg BW), Dose 2 (312.5 mg/kg BW), and Dose 3 (468.75 mg/kg BW). IgM and IgG were isolated from the spleen and analyzed using flow cytometry. Flow cytometry data were analyzed using SPSS with a one-way ANOVA and post hoc test (p-value <0.05). The analysis showed that the relative number of IgM-producing cells in the control group was significantly higher than in the treatment groups, with a difference of 44.40%. In contrast, the relative number of IgG-producing cells in Dose 3 was significantly lower than all other treatment groups, showing a decrease of 29.21%. Overall, the expression of IgG and IgM did not differ substantially across all treatments. The lower IgG and IgM profiles compared to the control group indicate Cheral®'s ability to prevent infections and maintain the immune system of the rats throughout the treatment period. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Role of Neutrophils as Therapeutic Targets in Intracerebral Hemorrhage.
- Author
-
Ardic, Alper Fatih and Ardic, Nurittin
- Subjects
INFLAMMATION prevention ,INFLAMMATORY mediators ,IMMUNOTHERAPY ,NEUTROPHILS ,IMMUNE system ,TREATMENT effectiveness ,MEDICAL research ,CEREBRAL hemorrhage ,CARDIOVASCULAR agents ,IMMUNOSUPPRESSION ,PHARMACODYNAMICS - Abstract
Intracerebral hemorrhage (ICH) is a major health problem. It is one of the most common types of stroke and results in mortality in approximately half of patients. More than half of the fatalities occur in the first 2 days. In addition to the mass effect after ICH hemorrhage, complex pathophysiological mechanisms such as intracranial vessel vasospasm, microthrombosis, and inflammatory immune reaction also increase brain damage. Both resident (including microglia and astrocytes) and circulating immune cells (including neutrophils, macrophages, and lymphocytes) involved in the inflammatory process. The inflammatory response is especially harmful in the acute phase due to harmful substances secreted by infiltrating immune cells. The inflammatory response also has beneficial effects, especially in the later stages. Their role in pathophysiology makes immune cells important therapeutic targets. General immunosuppressive approaches and depleting cell groups such as neutrophils or keeping them away from the lesion site may not be sufficient to prevent poor outcomes after ICH. This is most likely because they suppress anti-inflammatory activities and pro-inflammatory effects. Instead, directing immune cells to the beneficial subpopulation seems like a more rational solution. The pro-inflammatory N1 subpopulation of neutrophils damages the tissue surrounding ICH. In contrast, the N2 subpopulation is associated with anti-inflammatory reactions and tissue repair. Studies show that when neutrophils are polarized toward the N2 subpopulation, clinical outcomes improve and the volume of the infarct decreases. However, more research is still needed. This study aims to evaluate the role of neutrophils as immunotherapeutic targets in ICH in light of current knowledge. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. The function of long non-coding RNA IFNG-AS1 in autoimmune diseases.
- Author
-
Zhao, Jiale, Gui, Yibei, Wu, Wei, Li, Xueqing, Wang, Lijun, Wang, Hailin, Luo, Yiyang, Zhou, Gang, and Yuan, Chengfu
- Abstract
The prevalence of autoimmune diseases ranks as the third most common disease category globally, following cancer and heart disease. Numerous studies indicate that long non-coding RNA (lncRNA) plays a pivotal role in regulating human growth, development, and the pathogenesis of various diseases. It is more than 200 nucleotides in length and is mostly involve in the regulation of gene expression. Furthermore, lncRNAs are crucial in the development and activation of immune cells, with an expanding body of research exploring their association with autoimmune disorders in humans. LncRNA Ifng antisense RNA 1 (IFNG-AS1), a key regulatory factor in the immune system, also named NeST or TMEVPG1, is proximally located to IFNG and participates in the regulation of it. The dysregulation of IFNG-AS1 is implicated in the pathogenesis of several autoimmune diseases. This study examines the role and mechanism of IFNG-AS1 in various autoimmune diseases and considers its potential as a therapeutic target. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Immunglobulin E im Nasensekret.
- Author
-
Mühlmeier, Guido and Tisch, Matthias
- Abstract
Copyright of HNO is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
27. Exposure of cinnamyl alcohol in co‐culture of BEAS‐2B and dendritic cells: Interaction between CYP450 and cytokines.
- Author
-
Yoshizaki, Kelly, Frias, Daniela Perroni, Maier, Kevin, Smelan, Juliana, Correia, Aristides Tadeu, Oliveira, Luanda Mara da Silva, Amato‐Lourenço, Luís Fernando, Santillo, Bruna Tereso, Prado, Carla Máximo, Oshiro, Telma Miyuki, Barbuto, Jose Alexandre M., Mauad, Thais, and Macchione, Mariangela
- Subjects
THYMIC stromal lymphopoietin ,LIGANDS (Biochemistry) ,TRANSCRIPTION factors ,IMMUNE response ,IMMUNE system - Abstract
The prevalence of fragrances in various hygiene products contributes to their sensorial allure. However, fragrances can induce sensitization in the skin or respiratory system, and the mechanisms involved in this process are incompletely understood. This study investigated the intricate mechanisms underlying the fragrance's effects on sensitization response, focusing on the interplay between CYP450 enzymes, a class of drug‐metabolizing enzymes, and the adaptive immune system. Specifically, we assessed the expression of CYP450 enzymes and cytokine profiles in culture of BEAS‐2B and mature dendritic cells (mDC) alone or in co‐culture stimulated with 2 mM of a common fragrance, cinnamyl alcohol (CA) for 20 h. CYP1A1, CYP1A2, CYP1B1, CYP2A6, and CYP2A13 were analyzed by RT‐PCR and IL‐10, IL‐12p70, IL‐18, IL‐33, and thymic stromal lymphopoietin (TSLP) by Cytometric Bead Array (CBA). Through RT–PCR analysis, we observed that CA increased CYP1A2 and CYP1B1 expression in BEAS‐2B, with a further increased in BEAS‐2B‐mDC co‐culture. Additionally, exposure to CA increased IL‐12p70 levels in mDC rather than in BEAS‐2B‐mDC co‐culture. In regards to IL‐18, level was higher in BEAS‐2B than in BEAS‐2B‐mDC co‐culture. A positive correlation between the levels of IL‐10 and CYP1B1 was found in mDC‐CA‐exposed and between IL‐12p70 and CYP1A1 was found in BEAS‐2B after CA exposure. However, IL‐12p70 and CYP1A2 as well as IL‐18, IL‐33, and CYP1A1 levels were negative, correlated mainly in co‐culture control. These correlations highlight potential immunomodulatory interactions and complex regulatory relationships. Overall, exposure to CA enhances CYP450 expression, suggesting that CA can influence immune responses by degrading ligands on xenosensitive transcription factors. This study investigated mechanisms underlying the fragrance's effects on sensitization response through CYP450 enzymes and immune system. We quantified CYP450 enzymes and cytokines in BEAS‐2B and mature dendritic cells (mDC) alone or in co‐culture stimulated with 2 mM of cinnamyl alcohol (CA) for 20 h. Positive correlations between IL‐10 and CYP1B1 in mDC‐CA‐exposed and IL‐12p70 and CYP1A1 in BEAS‐2B‐CA‐exposed were found. These correlations highlight potential immunomodulatory interactions and regulatory relationships, suggesting that CA could influence immune responses by degrading ligands on xenosensitive transcription factors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Impacts of Apis cerana gut microbes on Nosema ceranae proliferation in Apis mellifera.
- Author
-
Wu, Zhihao, Wei, Xiuxiu, Zhang, Lizhen, Zeng, Zhijiang, Yan, Weiyu, and Huang, Qiang
- Abstract
The gut microbiota is a complex ecosystem including both beneficial and harmful microbes, which is essential for the metabolism, health and immunity of the host. Fecal microbiota transplantation (FMT) is an effective treatment for diseases of altered intestinal microbiota. Nosema ceranae, a parasitic fungus in intestinal epithelial cells, destroys the honey bee's gut integrity. This study provided the first report that the number of spores was significantly lower in the native host (Asian honey bee) compared with the novel host (European honey bee). The treatment effect of FMT was denoted by feeding the gut tissue solution from the original host to the new host. The results showed that FMT did not significantly decrease the spore load but enhanced the expression levels of immune genes in the Toll pathway. Our data confirmed that the native host inhibits N. ceranae proliferation. Our data suggest microbes of the native host could be an alternative approach to treat the parasite in the novel host. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Design and validation of novel flow cytometry panels to analyze a comprehensive range of peripheral immune cells in mice.
- Author
-
Barco-Tejada, Ainara, López-Esteban, Rocio, Mulero, Francisca, Pion, Marjorie, Correa-Rocha, Rafael, Desco, Manuel, and Cusso, Lorena
- Abstract
The use of flow cytometry in mice is constrained by several factors, including the limited availability of mouse-specific antibodies and the need to work with small volumes of peripheral blood. This is particularly challenging for longitudinal studies, as serial blood samples should not exceed 10% of the total blood volume in mice. To address this, we have developed two novel flow cytometry panels designed to extensively analyze immune cell populations in mice during longitudinal studies, using only 50 µL of peripheral blood per panel. Additionally, a third panel has been designed to conduct a more detailed analysis of cytotoxic and inhibitory markers at the end point. These panels have been validated on a lipopolysaccharide (LPS)-induced lung inflammation model. Two experiments were conducted to 1) validate the panels' sensitivity to immune challenges (n=12) and 2) to assess intrinsic variability of measurements (n=5). In both experiments, we collected 50 µL of peripheral blood for each cytometry panel from the maxillary venous sinus. All antibodies were titrated to identify the optimal concentration that maximized the signal from the positive population while minimizing the signal from the negative population. Samples were processed within 1 hour of collection using a MACSQuant Analyzer 16 cytometer. Our results demonstrate that these immunological panels are sensitive enough to detect changes in peripheral blood after LPS induction. Moreover, our findings help determine the sample size needed based on the immune population variability. In conclusion, the panels we have designed enable a comprehensive analysis of the murine immune system with a low blood volume requirement, enabling the measure of both absolute values and relative percentages effectively. This approach provides a robust platform for longitudinal studies in mice and can be used to uncover significant insights into immune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Pro- and anti-inflammatory cytokines: the hidden keys to autoimmune gastritis therapy.
- Author
-
Cascetta, Greta, Colombo, Giorgia, Eremita, Gianmarco, Garcia, Joe G. N., Lenti, Marco Vincenzo, Di Sabatino, Antonio, and Travelli, Cristina
- Abstract
Autoimmune gastritis (AIG) is an autoimmune disorder characterized by the destruction of gastric parietal cells and atrophy of the oxyntic mucosa which induces intrinsic factor deficiency and hypo-achlorhydria. AIG predominantly affects the antral mucosa with AIG patients experiencing increased inflammation and a predisposition toward the development of gastric adenocarcinoma and type I neuroendocrine tumors. The exact pathogenesis of this autoimmune disorder is incompletely understood although dysregulated immunological mechanisms appear to major contributors. This review of autoimmune gastritis, an unmet medical need, summarizes current knowledge on pro- and anti-inflammatory cytokines and strategies for the discovery of novel biomarkers and potential pharmacological targets. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. The immune factors involved in the rapid clearance of bacteria from the midgut of the tick Ixodes ricinus.
- Author
-
Guizzo, Melina Garcia, Frantová, Helena, Stephen Lu, Kozelková, Tereza, Číhalová, Kristýna, Dyčka, Filip, Hrbatová, Alena, Tonk-Rügen, Miray, Perner, Jan, Ribeiro, José M., Fogaça, Andrea C., Zurek, Ludek, and Kopáček, Petr
- Abstract
Ticks are obligate hematophagous arthropods that transmit a wide range of pathogens to humans as well as wild and domestic animals. They also harbor a non-pathogenic microbiota, although our previous study has shown that the diverse bacterial microbiome in the midgut of Ixodes ricinus is quantitatively poor and lacks a core. In artificial infections by capillary feeding of ticks with two model bacteria (Gram-positive Micrococcus luteus and Gram-negative Pantoea sp.), rapid clearance of these microbes from the midgut was observed, indicating the presence of active immune mechanisms in this organ. In the current study, RNAseq analysis was performed on the midgut of I. ricinus females inoculated with either M. luteus or Pantoea sp. or with sterile water as a control. While no immune-related transcripts were upregulated by microbial inoculation compared to that of the sterile control, capillary feeding itself triggered dramatic transcriptional changes in the tick midgut. Manual curation of the transcriptome from the midgut of unfed I. ricinus females, complemented by the proteomic analysis, revealed the presence of several constitutively expressed putative antimicrobial peptides (AMPs) that are independent of microbial stimulation and are referred to here as 'guard' AMPs. These included two types of midgut-specific defensins, two different domesticated amidase effector 2 (Dae2), microplusin/ricinusin-related molecules, two lysozymes, and two gamma interferon-inducible lysosomal thiol reductases (GILTs). The in vitro antimicrobial activity assays of two synthetic mature defensins, defensin 1 and defensin 8, confirmed their specificity against Gram-positive bacteria showing exceptional potency to inhibit the growth of M. luteus at nanomolar concentrations. The antimicrobial activity of midgut defensins is likely part of a multicomponent system responsible for the rapid clearance of bacteria in the tick midgut. Further studies are needed to evaluate the role of other identified 'guard' AMPs in controlling microorganisms entering the tick midgut. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome.
- Author
-
Sarvestani, Mojtaba, Rajabzadeh, Alireza, Mazoochi, Tahereh, Samimi, Mansooreh, Navari, Mohsen, and Moradi, Faezeh
- Subjects
- *
LIVER physiology , *OVARIAN physiology , *POLYCYSTIC ovary syndrome treatment , *PLACENTA , *HIGH density lipoproteins , *OVARIAN follicle , *RESEARCH funding , *MESENCHYMAL stem cells , *HYPERANDROGENISM , *LIPIDS , *ASPARTATE aminotransferase , *TREATMENT effectiveness , *IMMUNE system , *RATS , *EXPERIMENTAL design , *INSULIN resistance , *ANIMAL experimentation , *FOLLICLE-stimulating hormone , *LUTEINIZING hormone , *ANALYSIS of variance , *ALANINE aminotransferase , *TRIGLYCERIDES , *DATA analysis software , *OVARIES - Abstract
Introduction: Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disturbance that affects many women worldwide and is characterized by chronic anovulation, hyperandrogenism, and ovarian dysfunction. Placenta-derived mesenchymal stem cells (PDMSCs) are derived from the placenta and have advantages over other sources of MSCs in terms of availability, safety, and immunomodulation. Materials and methods: In this experimental study, twenty female Wistar rats were assigned to four groups (n = 5) including control, sham, PCOS, and PCOS+PDMSCs groups. Then, PCOS was induced in the rats through administering letrozole for 21 days. PDMSCs (1 × 106 cells) were injected through the tail vein. Fourteen days after the cell infusion, evaluation was performed on the number of healthy follicles, corpus luteum, and cystic follicles as well as the levels of testosterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), fasting blood glucose, fasting insulin, and insulin resistance. Moreover, the serum levels of cholesterol, triglyceride (TG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) were measured. Liver function was also determined by the evaluation of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. Results: The number of corpus luteum and primordial, primary, secondary, and antral follicles was significantly elevated in the PCOS+PDMSCs group compared to the PCOS group. However, the number of cystic follicles significantly decreased in the PCOS+PDMSCs group. The LH and testosterone levels also decreased significantly, while FSH levels increased significantly in the PCOS+PDMSCs group. The levels of fasting blood glucose, fasting insulin, and insulin resistance notably decreased in the PCOS+PDMSCs group. Moreover, the lipid profile improved in the PCOS+PDMSCs group along with a significant decrease of cholesterol, LDL, and TG and an increase in HDL. The PCOS+PDMSCs group exhibited marked decreases in the AST and ALT levels as well. Conclusion: The results of this study suggest that PDMSCs are a potential treatment option for PCOS because they can effectively restore folliculogenesis and correct hormonal imbalances, lipid profiles and liver dysfunction in a rat model of PCOS. However, further research is needed to establish the safety and effectiveness of PDMSCs for treating PCOS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Macrophage Colony Stimulating Factor (M‐CSF) and Interleukin‐34 (IL‐34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune Microenvironment.
- Author
-
Robinson, Christopher J., Moeller, Cambri E., Quick, Cally N., Goodermuth, Christine E., Carossino, Mariano, and Withers, Sita S.
- Subjects
- *
MACROPHAGE colony-stimulating factor , *GENE expression , *CELL lines , *TUMOR microenvironment , *IMMUNE system - Abstract
ABSTRACT Canine osteosarcoma (OSA) is a malignancy that has been shown to modulate the host immune system. Macrophage colony‐stimulating factor (M‐CSF; CSF1) and interleukin‐34 (IL‐34; IL34) are both ligands of colony stimulating factor 1 receptor (CSF‐1R), and may play a role in the pathogenesis of a variety of human cancers, including OSA. This study aimed to, (1) assess M‐CSF and IL‐34 expression in canine OSA cell lines and tissue samples, and (2) determine any correlations between M‐CSF and IL‐34 expression and immune cell infiltrates within canine OSA tissues. Four canine OSA cell lines and canine osteoblasts were treated with control media, TNFα (10 ng/mL) or IL‐1β (10 ng/mL) and analysed with RT‐qPCR and ELISA. IL‐34 and M‐CSF mRNA and protein were detectable in all cell lines, however upregulation following TNFα or IL‐1β exposure was only consistently observed for transcript expression. Baseline expression of CSF1 and IL34 mRNA in OSA cell lines was equal to or higher than that of canine osteoblasts. All 10 OSA tissue samples expressed IL34 and CSF1 transcripts to varying degrees. Furthermore, CSF1 and IL34 expression both showed a moderate to high degree of correlation with M1 macrophage lineage‐associated transcripts (CD80 and IL15RA). There was a moderate degree of correlation between CSF1 and CD163, but no correlation between IL34 and either M2 macrophage‐associated transcripts (CD163 and CCL24). In summary, IL‐34 and M‐CSF are expressed in canine OSA cell lines and tissues, and expression positively correlates with a wide range of immune‐related transcripts. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Improving undergraduate education in immunology through assessment of interdisciplinary scientific knowledge.
- Author
-
Baty, Joshua J, Patel, Isha, Taylor, Jared P, Graben, Connor, Deaver, Jill, Justement, Louis B, and Bruns, Heather A
- Subjects
- *
ASSESSMENT of education , *UNDERGRADUATE programs , *INTERDISCIPLINARY education , *IMMUNE system ,UNDERGRADUATE education - Abstract
The interdisciplinary nature of immunology can make studying not only engaging but also challenging, as understanding immunologic processes and immune system components requires foundational knowledge from several science disciplines. The University of Alabama at Birmingham has a unique, 4‐year, Undergraduate Immunology Program (UIP) that provides a comprehensive curriculum in immunology that includes five core courses starting in the second year, at which point, students are in the process of completing basic science sequences. For this study, students in courses across the UIP curriculum were asked to identify basic science topics that relate to four immunology concepts. In addition, students were surveyed on their confidence in understanding each of the basic science topics and were asked to identify the course in which they felt that they had fully learned the topic. Data from this study did not demonstrate a change in students’ interdisciplinary science competency from the second to fourth year. Importantly, students reported that they fully understood 11 out of 12 basic science concepts in courses offered in their first and second years, with confidence in basic science topics significantly improving from the second to third year. The lack of demonstrated improvement in interdisciplinary understanding across the curriculum may be attributed to the fact that students are able to integrate basic science topics with foundational immunologic concepts as early as their second year. Importantly, these findings suggest that the integration or review of basic science topics in an immunology course may improve students’ comprehension of foundational immunology concepts and interdisciplinary science competency. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. The role of nociceptive neurons in allergic rhinitis.
- Author
-
Jianchao Cong, Hao Lv, and Yu Xu
- Abstract
Allergic rhinitis (AR) is a chronic, non-infectious condition affecting the nasal mucosa, primarily mediated mainly by IgE. Recent studies reveal that AR is intricately associated not only with type 2 immunity but also with neuroimmunity. Nociceptive neurons, a subset of primary sensory neurons, are pivotal in detecting external nociceptive stimuli and modulating immune responses. This review examines nociceptive neuron receptors and elucidates how neuropeptides released by these neurons impact the immune system. Additionally, we summarize the role of immune cells and inflammatory mediators on nociceptive neurons. A comprehensive understanding of the dynamic interplay between nociceptive neurons and the immune system augments our understanding of the neuroimmune mechanisms underlying AR, thereby opening novel avenues for AR treatment modalities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Cannabinoids and triple-negative breast cancer treatment.
- Author
-
Dobovišek, Luka, Borštnar, Simona, Debeljak, Nataša, and Brezar, Simona Kranjc
- Abstract
Triple-negative breast cancer (TNBC) accounts for about 10-20% of all breast cancer cases and is associated with an unfavorable prognosis. Until recently, treatment options for TNBC were limited to chemotherapy. A new successful systemic treatment is immunotherapy with immune checkpoint inhibitors, but new tumor-specific biomarkers are needed to improve patient outcomes. Cannabinoids show antitumor activity in most preclinical studies in TNBC models and do not appear to have adverse effects on chemotherapy. Clinical data are needed to evaluate efficacy and safety in humans. Importantly, the endocannabinoid system is linked to the immune system and immunosuppression. Therefore, cannabinoid receptors could be a potential biomarker for immune checkpoint inhibitor therapy or a novel mechanism to reverse resistance to immunotherapy. In this article, we provide an overview of the currently available information on how cannabinoids may influence standard therapy in TNBC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. 口腔疾病与抑郁症的关系.
- Author
-
梁潇月, 任彪, and 周学东
- Abstract
Copyright of Journal of Prevention & Treatment For Stomatological Diseases is the property of Journal of Prevention & Treatment For Stomatological Diseases Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
38. Exploring the dynamic landscape of immunopeptidomics: Unravelling posttranslational modifications and navigating bioinformatics terrain.
- Author
-
Flender, Daniel, Vilenne, Frédérique, Adams, Charlotte, Boonen, Kurt, Valkenborg, Dirk, and Baggerman, Geert
- Subjects
- *
POST-translational modification , *CURATIVE medicine , *INDIVIDUALIZED medicine , *IMMUNE system , *PROTEOMICS - Abstract
Immunopeptidomics is becoming an increasingly important field of study. The capability to identify immunopeptides with pivotal roles in the human immune system is essential to shift the current curative medicine towards personalized medicine. Throughout the years, the field has matured, giving insight into the current pitfalls. Nowadays, it is commonly accepted that generalizing shotgun proteomics workflows is malpractice because immunopeptidomics faces numerous challenges. While many of these difficulties have been addressed, the road towards the ideal workflow remains complicated. Although the presence of Posttranslational modifications (PTMs) in the immunopeptidome has been demonstrated, their identification remains highly challenging despite their significance for immunotherapies. The large number of unpredictable modifications in the immunopeptidome plays a pivotal role in the functionality and these challenges. This review provides a comprehensive overview of the current advancements in immunopeptidomics. We delve into the challenges associated with identifying PTMs within the immunopeptidome, aiming to address the current state of the field. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs.
- Author
-
Favalli, Ennio Giulio, Maioli, Gabriella, and Caporali, Roberto
- Subjects
- *
BIOTHERAPY , *THROMBOEMBOLISM risk factors , *PATIENT compliance , *RISK assessment , *REPRODUCTIVE health , *RHEUMATOID arthritis , *SEX distribution , *VEINS , *ANTIRHEUMATIC agents , *IMMUNE system , *AGE distribution , *INFECTION , *INTERSTITIAL lung diseases , *JANUS kinases , *MONOCLONAL antibodies , *LACTATION , *DRUG efficacy , *NEUROTRANSMITTER uptake inhibitors , *HEALTH outcome assessment , *PATIENT decision making , *COMORBIDITY , *OBESITY , *PHARMACODYNAMICS - Abstract
Rheumatoid arthritis (RA) is a chronic immune-mediated inflammatory disease which can induce progressive disability if not properly treated early. Over the last 20 years, the improvement of knowledge on the pathogenesis of the disease has made available several drugs targeting key elements of the pathogenetic process, which now represent the preferred treatment option after the failure of first-line therapy with conventional drugs such as methotrexate (MTX). To this category of targeted drugs belong anti-cytokine or cell-targeted biological agents and more recently also Janus kinase inhibitors (JAKis). In the absence to date of specific biomarkers to guide the therapeutic choice in the context of true precision medicine, the choice of the first targeted drug after MTX failure is guided by treatment cost (especially after the marketing of biosimilar products) and by the clinical characteristics of the patient (age, sex, comorbidities and compliance) and the disease (presence or absence of autoantibodies and systemic or extra-articular manifestations), which may influence the efficacy and safety profile of the available products. This viewpoint focuses on the decision-making process underlying the personalized approach to RA therapy and will analyse the evidence in the literature supporting the choice of individual products and in particular the differential choice between biological drugs and JAKis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials.
- Author
-
Sherman, Amy C, Tuan, Jessica, Cantos, Valeria D, Adeyiga, Oladunni, Mahoney, Scott, Ortega-Villa, Ana M, Tillman, Amy, Whitaker, Jennifer, Davis, Amanda S Woodward, Leav, Brett, Hirsch, Ian, Sadoff, Jerald, Dunkle, Lisa M, Gilbert, Peter B, Janes, Holly E, Kublin, James G, Goepfert, Paul A, Kotloff, Karen, Rouphael, Nadine, and Falsey, Ann R
- Subjects
- *
NUTRITION disorders , *PLACEBOS , *VACCINE effectiveness , *IMMUNOCOMPROMISED patients , *STATISTICAL sampling , *IMMUNE system , *COVID-19 vaccines , *RANDOMIZED controlled trials , *PHARMACEUTICAL industry - Abstract
Background Although the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are highly efficacious at preventing severe disease in the general population, current data are lacking regarding vaccine efficacy (VE) for individuals with mild immunocompromising conditions. Methods A post hoc, cross-protocol analysis of participant-level data from the blinded phase of four randomized, placebo-controlled, coronavirus disease 2019 (COVID-19) vaccine phase 3 trials (Moderna, AstraZeneca, Janssen, and Novavax) was performed. We defined a "tempered immune system" (TIS) variable via a consensus panel based on medical history and medications to determine VE against symptomatic and severe COVID-19 cases in TIS participants versus non-TIS individuals starting at 14 days after completion of the primary series through the blinded phase for each of the 4 trials. An analysis of participants living with well-controlled human immunodeficiency virus was conducted using the same methods. Results A total of 3852/30 351 (12.7%) Moderna participants, 3088/29 868 (10.3%) Novavax participants, 3549/32 380 (11.0%) AstraZeneca participants, and 5047/43 788 (11.5%) Janssen participants were identified as having a TIS. Most TIS conditions (73.9%) were due to metabolism and nutritional disorders. Vaccination (vs placebo) significantly reduced the likelihood of symptomatic and severe COVID-19 for all participants for each trial. VE was not significantly different for TIS participants versus non-TIS for either symptomatic or severe COVID-19 for each trial, nor was VE significantly different in the symptomatic endpoint for participants with human immunodeficiency virus. Conclusions For individuals with mildly immunocompromising conditions, there is no evidence of differences in VE against symptomatic or severe COVID-19 compared with those with non-TIS in the 4 COVID-19 vaccine randomized controlled efficacy trials. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Recent advances in the molecular understanding of immunoglobulin A.
- Author
-
Wang, Yuxin and Xiao, Junyu
- Subjects
- *
EPITHELIAL cells , *IMMUNOGLOBULIN A , *IMMUNE system , *IMMUNOGLOBULIN receptors , *MONOMERS , *IMMUNOGLOBULINS - Abstract
Immunoglobulin A (IgA) plays a crucial role in the human immune system, particularly in mucosal immunity. IgA antibodies that target the mucosal surface are made up of two to five IgA monomers linked together by the joining chain, forming polymeric molecules. These IgA polymers are transported across mucosal epithelial cells by the polymeric immunoglobulin receptor pIgR, resulting in the formation of secretory IgA (SIgA). This review aims to explore recent advancements in our molecular understanding of IgA, with a specific focus on SIgA, and the interaction between IgA and pathogen molecules. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Unravelling CD24‐Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studies.
- Author
-
Hazra, Rudradeep, Chattopadhyay, Soumyadeep, Mallick, Arijit, Gayen, Sakuntala, and Roy, Souvik
- Subjects
- *
MEMBRANE glycoproteins , *TUMOR microenvironment , *IMMUNOLOGICAL tolerance , *IMMUNE response , *IMMUNE system - Abstract
Cancer immunotherapy has revolutionized the treatment landscape by harnessing the power of the immune system to combat malignancies. Two of the most promising players in this field are cluster of differentiation 24 (CD24) and sialic acid‐binding Ig‐like lectin 10 (Siglec‐10), and both of them play pivotal roles in modulating immune responses. CD24, a cell surface glycoprotein, emerges as a convincing fundamental signal transducer for therapeutic intervention, given its significant implication in the processes related to tumour progression and immunogenic evasion. Additionally, the immunomodulatory functions of Siglec‐10, a prominent member within the Siglec family of immune receptors, have recently become a crucial point of interest, particularly in the context of the tumour microenvironment. Hence, the intricate interplay of both CD24 and Siglec‐10 assumes a critical role in fostering tumour growth, facilitating metastasis and also orchestrating immune evasion. Recent studies have found multiple evidences supporting the therapeutic potential of targeting CD24 in cancer treatment. Siglec‐10, on the other hand, exhibits immunosuppressive properties that contribute to immune tolerance within the tumour microenvironment. Therefore, we delve into the complex mechanisms through which Siglec‐10 modulates immune responses and facilitates immune escape in cancer. Siglec‐10 also acts as a viable target for cancer immunotherapy and presents novel avenues for the development of therapeutic interventions. Furthermore, we examine the synergy between CD24 and Siglec‐10 in shaping the immunosuppressive tumour microenvironment and discuss the implications for combination therapies. Therefore, understanding the roles of CD24 and Siglec‐10 in cancer immunotherapy opens exciting possibilities for the development of novel therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. The relationship of redox signaling with the risk for atherosclerosis.
- Author
-
Sujuan Lei, Chen Liu, Tian-xiang Zheng, Wenguang Fu, and Mei-zhou Huang
- Subjects
OXIDATIVE stress ,CELLULAR signal transduction ,ATHEROSCLEROSIS ,UNHEALTHY lifestyles ,IMMUNE system ,HOMEOSTASIS - Abstract
Oxidative balance plays a pivotal role in physiological homeostasis, and many diseases, particularly age-related conditions, are closely associated with oxidative imbalance. While the strategic role of oxidative regulation in various diseases is well-established, the specific involvement of oxidative stress in atherosclerosis remains elusive. Atherosclerosis is a chronic inflammatory disorder characterized by plaque formation within the arteries. Alterations in the oxidative status of vascular tissues are linked to the onset, progression, and outcome of atherosclerosis. This review examines the role of redox signaling in atherosclerosis, including its impact on risk factors such as dyslipidemia, hyperglycemia, inflammation, and unhealthy lifestyle, along with dysregulation, vascular homeostasis, immune system interaction, and therapeutic considerations. Understanding redox signal transduction and the regulation of redox signaling will offer valuable insights into the pathogenesis of atherosclerosis and guide the development of novel therapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis.
- Author
-
Unterman, Avraham, Zhao, Amy Y., Neumark, Nir, Schupp, Jonas C., Ahangari, Farida, Cosme Jr., Carlos, Sharma, Prapti, Flint, Jasper, Stein, Yan, Ryu, Changwan, Ishikawa, Genta, Sumida, Tomokazu S., Gomez, Jose L., Herazo-Maya, Jose D., Dela Cruz, Charles S., Herzog, Erica L., and Kaminski, Naftali
- Subjects
IDIOPATHIC pulmonary fibrosis ,MONONUCLEAR leukocytes ,REGULATORY T cells ,CELL populations ,BLOOD cells ,T cell receptors - Abstract
Rationale: Changes in peripheral blood cell populations have been observed, but not detailed, at single-cell resolution in idiopathic pulmonary fibrosis (IPF). Objectives: We sought to provide an atlas of the changes in the peripheral immune system in stable and progressive IPF. Methods: Peripheral blood mononuclear cells (PBMCs) from patients with IPF and control subjects were profiled using 10× chromium 5′ single-cell RNA sequencing. Flow cytometry was used for validation. Protein concentrations of regulatory T cells (Tregs) and monocyte chemoattractants were measured in plasma and lung homogenates from patients with IPF and control subjects. Measurements and Main Results: Thirty-eight PBMC samples from 25 patients with IPF and 13 matched control subjects yielded 149,564 cells that segregated into 23 subpopulations. Classical monocytes were increased in patients with progressive and stable IPF compared with control subjects (32.1%, 25.2%, and 17.9%, respectively; P < 0.05). Total lymphocytes were decreased in patients with IPF versus control subjects and in progressive versus stable IPF (52.6% vs. 62.6%, P = 0.035). Tregs were increased in progressive versus stable IPF (1.8% vs. 1.1% of all PBMCs, P = 0.007), although not different than controls, and may be associated with decreased survival (P = 0.009 in Kaplan-Meier analysis; and P = 0.069 after adjusting for age, sex, and baseline FVC). Flow cytometry analysis confirmed this finding in an independent cohort of patients with IPF. The fraction of Tregs out of all T cells was also increased in two cohorts of lung single-cell RNA sequencing. CCL22 and CCL18, ligands for CCR4 and CCR8 Treg chemotaxis receptors, were increased in IPF. Conclusions: The single-cell atlas of the peripheral immune system in IPF reveals an outcome-predictive increase in classical monocytes and Tregs, as well as evidence for a lung–blood immune recruitment axis involving CCL7 (for classical monocytes) and CCL18/CCL22 (for Tregs). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Crosstalk between gut microbiota and host immune system and its response to traumatic injury.
- Author
-
Ullah, Hanif, Arbab, Safia, Yali Tian, Yuwen Chen, Chang-qing Liu, Qijie Li, and Ka Li
- Subjects
GUT microbiome ,BACTERIAL metabolism ,DYSBIOSIS ,HOMEOSTASIS ,PROBIOTICS - Abstract
Millions of microorganisms make up the complex microbial ecosystem found in the human gut. The immune system's interaction with the gut microbiota is essential for preventing inflammation and maintaining intestinal homeostasis. Numerous metabolic products that can cross-talk between immune cells and the gut epithelium are metabolized by the gut microbiota. Traumatic injury elicits a great and multifaceted immune response in the minutes after the initial offense, containing simultaneous pro- and anti-inflammatory responses. The development of innovative therapies that improve patient outcomes depends on the gut microbiota and immunological responses to trauma. The altered makeup of gut microbes, or gut dysbiosis, can also dysregulate immunological responses, resulting in inflammation. Major human diseases may become more common as a result of chronic dysbiosis and the translocation of bacteria and the products of their metabolism beyond the mucosal barrier. In this review, we briefly summarize the interactions between the gut microbiota and the immune system and human disease and their therapeutic probiotic formulations. We also discuss the immune response to traumatic injury. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy.
- Author
-
Guangtan Du, Cunmiao Dou, Peng Sun, Shasha Wang, Jia Liu, and Leina Ma
- Subjects
REGULATORY T cells ,TUMOR microenvironment ,LIVER cancer ,HEPATOCELLULAR carcinoma ,IMMUNE system - Abstract
Liver cancer, which most commonly manifests as hepatocellular carcinoma (HCC), is the sixth most common cancer in the world. In HCC, the immune system plays a crucial role in the growth and proliferation of tumor cells. HCC achieve immune escape through the tumor microenvironment, which significantly promotes the development of this cancer. Here, this article introduces and summarizes the functions and effects of regulatory T cells (Tregs) in the tumor microenvironment, highlighting how Tregs inhibit and regulate the functions of immune and tumor cells, cytokines, ligands and receptors, etc, thereby promoting tumor immune escape. In addition, it discusses the mechanism of CAR-T therapy for HCC and elaborate on the relationship between CAR-T and Tregs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Current status and future directions of nanovaccine for cancer: a bibliometric analysis during 2004-2023.
- Author
-
Yuhui Hou, Yue Li, Youao Zhang, Juan Zhang, and Dinglan Wu
- Subjects
BIBLIOMETRICS ,VACCINE effectiveness ,INDIVIDUALIZED medicine ,IMMUNE system ,IMMUNE response - Abstract
Background: Nanovaccine treatment is an exciting area of research in immunology and personalized medicine, holding great promise for enhancing immune responses and targeting specific diseases. Their small size allows efficient uptake by immune cells, leading to robust immune activation. They can incorporate immune-stimulating molecules to boost vaccine efficacy. Therefore, nanovaccine can be personalized to target tumor-specific antigens, activating the immune system against cancer cells. Currently, there have been ample evidence showing the effectiveness and potential of nanovaccine as a treatment for cancer. However, there was rare bibliometric analysis of nanovaccine for cancer. Here we performed a bibliometric and visual analysis of published studies related to nanovaccine treatment for cancer, providing the trend of future development of nanovaccine. Methods: We collected the literatures based on the Web of Science Core Collection SCI-Expanded database. The bibliometric analysis was performed via utilizing visualization analysis tools VOSviewer, Co-Occurrence (COOC), Citespace, Bibliometrix (R-Tool of R-Studio), and HitCite. Results: A total of 517 literatures were included in this study. China is the country with the most publications and the highest total local citation score (TLCS). The Chinese Academy of Sciences holds the largest research count in this field and the most prolific author is Deling Kong from Nankai University. The most prominent journal for publishing in this area is Biomaterials. The researches mainly focus on the therapeutic process of tumor nanovaccines, the particle composition and the application of nanovaccines, suggesting the potential hotspots and trends of nanovaccine. Conclusion: In this study, we summarized the characteristics and variation trends of publications involved in nanovaccine, and categorized the most influential countries, institutions, authors, journals, hotspots and trends regarding the nanovaccine for cancer. With the continuous development of nanomaterials and tumor immunotherapy, nanovaccine for cancer provides a research field of significant clinical value and potential application. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Therapeutic strategies focusing on immune dysregulation and neuroinflammation in rosacea.
- Author
-
Kuan-Yi Tu, Chiau-Jing Jung, Yi-Hsien Shih, and Chang, Anne Lynn S.
- Subjects
ORAL medication ,IMMUNE system ,GENETICS ,DYSBIOSIS ,NEUROINFLAMMATION ,ROSACEA - Abstract
Rosacea is a complex inflammatory condition characterized by papulopustular lesions and erythema on the central face for which there is no cure. The development of rosacea is influenced by both external triggers and genetics, but the common pathophysiology is overactivation of the immune system. Here, we review the current data on proinflammatory cytokines and dysregulation of the neurovascular system as targetable components of rosacea. Amelioration of cutaneous and gastrointestinal dysbiosis and other external factors impacts the immune state and has been observed to improve rosacea. While multiple treatments exist, many patients do not achieve their goals for rosacea control and highlights an unmet need for dermatologic care. Current interventions encompass topical/oral drugs, light devices, and avoidance of triggers management. Additional understanding of the underlying pathogenesis may help us develop novel targeted therapeutic strategies to improve rosacea. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Balancing immune responses: regulatory cells in eosinophilic gastrointestinal disorders.
- Author
-
Kheshtchin, Nassim, Kanannejad, Zahra, Ghahramani, Zahra, Esmaeilzadeh, Hossein, and Sepahi, Najmeh
- Subjects
REGULATORY T cells ,EOSINOPHILS ,CELL physiology ,T cells ,IMMUNE response - Abstract
Eosinophilic gastrointestinal disorders (EGIDs) are a group of conditions characterized by an abnormal accumulation of eosinophils in the gastrointestinal tract, leading to inflammation and tissue damage. Regulatory cells are a subset of immune cells that are crucial in maintaining the balance of the immune system and preventing the occurrence of autoimmune diseases. In EGIDs, regulatory cells are believed to play a key role in controlling the immune response and overseeing the growth and activation of eosinophils in the gastrointestinal tract. There is evidence indicating that regulatory T cells (Tregs) and regulatory eosinophils may play a role in suppressing the inflammatory response in EGIDs. Regulatory eosinophils are a subgroup of eosinophils that possess an anti-inflammatory role. Recent studies have shown that enhancing the number or effectiveness of regulatory eosinophils can reduce the severity of EGIDs. Regulatory eosinophils dampen inflammation through their regulatory mediators, such as galectin-10 and growth factor beta (TGF-β), which promote Treg expansion and inhibit effector T cell function. Further research on regulatory cells in EGIDs may have significant implications for the advancement of novel therapies for these uncommon and intricate disorders. The aim of this review is to provide complete view of the immune responses connected to EGIDs, examine the regulatory cells that control these responses, and evaluate their potential as therapeutic targets for EGID treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. The intratumoral microbiota: a new horizon in cancer immunology.
- Author
-
Wei Liu, Yuming Li, Ping Wu, Xinyue Guo, Yifei Xu, Lianhai Jin, and Donghai Zhao
- Subjects
NUCLEOTIDE sequencing ,TUMOR microenvironment ,HUMAN microbiota ,CLINICAL medicine ,IMMUNE system - Abstract
Over the past decade, advancements in high-throughput sequencing technologies have led to a qualitative leap in our understanding of the role of the microbiota in human diseases, particularly in oncology. Despite the low biomass of the intratumoral microbiota, it remains a crucial component of the tumor immune microenvironment, displaying significant heterogeneity across different tumor tissues and individual patients. Although immunotherapy has emerged a major strategy for treating tumors, patient responses to these treatments vary widely. Increasing evidence suggests that interactions between the intratumoral microbiota and the immune system can modulate host tumor immune responses, thereby influencing the effectiveness of immunotherapy. Therefore, it is critical to gain a deep understanding of how the intratumoral microbiota shapes and regulates the tumor immune microenvironment. Here, we summarize the latest advancements on the role of the intratumoral microbiota in cancer immunity, exploring the potential mechanisms through which immune functions are influenced by intratumoral microbiota within and outside the gut barrier. We also discuss the impact of the intratumoral microbiota on the response to cancer immunotherapy and its clinical applications, highlighting future research directions and challenges in this field. We anticipate that the valuable insights into the interactions between cancer immunity and the intratumoral microbiota provided in this review will foster the development of microbiota-based tumor therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.